Therapeutic Advances in Depletive Management of Heart Failure
Main Article Content
Keywords
References
1. Rodríguez Roca G, Luis Llisterri Caro J, Javier Alonso Moreno F, Barrios Alonso V, Rodríguez Padial L. La insuficiencia cardíaca congestiva en atención primaria (y II). Semer - Med Fam [Internet]. 2000;26(2):66–76. Disponible en: doi:10.1016/s1138-3593(00)73536-2
2. Gómez-Mesa JE, Saldarriaga CI, Echeverría LE, Luna P. Colombian heart failure registry (RECOLFACA): methodology and preliminary data. Rev Colomb Cardiol [Internet]. 2021;28(3):217–30. Disponible en: doi:10.24875/RCCAR.M21000021
3. Gheorghiade M, Filippatos G. Reassessing treatment of acute heart failure syndromes: The ADHERE Registry. Eur Hear Journal, Suppl [Internet]. 2005;7(B):13–9. Disponible en: doi:10.1093/eurheartj/sui008
4. Biegus J, Zymlinski R, Siwolowski P, Testani J, Szachniewicz J, Tycińska A, et al. Controlled decongestion by Reprieve therapy in acute heart failure: results of the TARGET-1 and TARGET-2 studies. Eur J Heart Fail [Internet]. 2019;21(9):1079–87. Disponible en: doi:10.1002/ejhf.1533
5. Magenta Medical Ltd. Clinical Evaluation of the TRVD TM System in ADHF ( TRVD) [Internet]. 2019. Disponible en: https://clinicaltrials.gov/ct2/show/study/NCT03621436
6. WhiteSwell Ltd. Safety and Feasibility of the WhiteSwell System " (SWIFTHF) [Internet]. 2022. p. 1–4. Disponible en: https://clinicaltrials.gov/ct2/show/NCT02863796
7. AquaPass Medical Ltd. Effect of Enhanced Sweat Rate on the Safety and Edema Status of Chronic Edematous Patients [Internet]. 2022. Disponible en: https://clinicaltrials.gov/ct2/show/NCT04578353
2. Gómez-Mesa JE, Saldarriaga CI, Echeverría LE, Luna P. Colombian heart failure registry (RECOLFACA): methodology and preliminary data. Rev Colomb Cardiol [Internet]. 2021;28(3):217–30. Disponible en: doi:10.24875/RCCAR.M21000021
3. Gheorghiade M, Filippatos G. Reassessing treatment of acute heart failure syndromes: The ADHERE Registry. Eur Hear Journal, Suppl [Internet]. 2005;7(B):13–9. Disponible en: doi:10.1093/eurheartj/sui008
4. Biegus J, Zymlinski R, Siwolowski P, Testani J, Szachniewicz J, Tycińska A, et al. Controlled decongestion by Reprieve therapy in acute heart failure: results of the TARGET-1 and TARGET-2 studies. Eur J Heart Fail [Internet]. 2019;21(9):1079–87. Disponible en: doi:10.1002/ejhf.1533
5. Magenta Medical Ltd. Clinical Evaluation of the TRVD TM System in ADHF ( TRVD) [Internet]. 2019. Disponible en: https://clinicaltrials.gov/ct2/show/study/NCT03621436
6. WhiteSwell Ltd. Safety and Feasibility of the WhiteSwell System " (SWIFTHF) [Internet]. 2022. p. 1–4. Disponible en: https://clinicaltrials.gov/ct2/show/NCT02863796
7. AquaPass Medical Ltd. Effect of Enhanced Sweat Rate on the Safety and Edema Status of Chronic Edematous Patients [Internet]. 2022. Disponible en: https://clinicaltrials.gov/ct2/show/NCT04578353
Article Sidebar
Published
Sep 5, 2023
Article Details
How to Cite
Serna–Trejos, J. S., Bermúdez – Moyano, S. G., & Prado–Molina, D. G. (2023). Therapeutic Advances in Depletive Management of Heart Failure. Hispano-American Journal of Health Sciences, 9(2), 164–165. https://doi.org/10.56239/rhcs.2023.92.651
Section
Cartas al Editor
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
RHCS uses the Creative Commons License 4.0 International (CC BY 4.0). For more information, please visit